Incidence and predictors of ovarian function recovery (OFR) in breast cancer (BC) patients with chemotherapy-induced amenorrhea (CIA) who switched from tamoxifen to exemestane

Author： Guerrero A.   Gavil J.   Folkerd E.   Ortiz B.   Martnez F.   Garca A.   Climent M. A.   Guillem V.   Ruz A.  

Publisher： Oxford University Press

ISSN： 0923-7534

Source： Annals of Oncology, Vol.24, Iss.3, 2013-03, pp. : 674-679

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane

By Okanami Yuko  

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 182-188

Springer Publishing Company

Access to resources Recommend Favorite

The Clinical Outcome of Chemotherapy-Induced Amenorrhea in Premenopausal Young Patients with Breast Cancer with Long-Term Follow-up

By Jung Minkyu  

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3259-3268

Springer Publishing Company

Access to resources Recommend Favorite

Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study

By Schilder Christina   Eggens Petronella   Seynaeve Caroline   Linn Sabine   Boogerd Willem   Gundy Chad   Beex Louk   Van Dam Frits   Schagen Sanne  

Acta Oncologica, Vol. 48, Iss. 1, 2009-01 ,pp. : 76-85

Informa Healthcare

Access to resources Recommend Favorite

Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications

By del Mastro L.   Venturini M.   Roberto Sertoli M.   Rosso R.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 2, 1997-04 ,pp. : 183-190

Springer Publishing Company

Access to resources Recommend Favorite

Ovarian Histopathology in Breast Cancer Patients Receiving Tamoxifen

By McGonigle K.F.   Vasilev S.A.   Odom-Maryon T.   Simpson J.F.  

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 402-406

Elsevier

Access to resources Recommend Favorite